Terms: = Breast cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Clinical Outcome
28 results:
1. Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer.
Kuroda H; Jamiyan T; Yamaguchi R; Kakumoto A; Abe A; Harada O; Enkhbat B; Masunaga A
Breast Cancer; 2021 Jul; 28(4):904-914. PubMed ID: 33629216
[TBL] [Abstract] [Full Text] [Related]
2. HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer.
Nanou A; Zeune LL; Bidard FC; Pierga JY; Terstappen LWMM
Breast Cancer Res; 2020 Aug; 22(1):86. PubMed ID: 32787900
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic impact of a tumor-infiltrating lymphocyte subtype in triple negative cancer of the breast.
Jamiyan T; Kuroda H; Yamaguchi R; Nakazato Y; Noda S; Onozaki M; Abe A; Hayashi M
Breast Cancer; 2020 Sep; 27(5):880-892. PubMed ID: 32222891
[TBL] [Abstract] [Full Text] [Related]
4. [Prognostic values of grading system for lymph vessel tumor emboli in patients with invasive breast carcinomas of no special type].
Yue M; Li F; Deng HY; Zhang LL; Liu YP
Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):754-758. PubMed ID: 29061019
[No Abstract] [Full Text] [Related]
5. Comparative safety and efficacy of tyrosine kinase inhibitors (TKIs) in the treatment setting of different types of leukemia, and different types of adenocarcinoma.
Yazdi MH; Faramarzi MA; Nikfar S; Abdollahi M
Biomed Pharmacother; 2017 Nov; 95():1556-1564. PubMed ID: 28950655
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic impact of the inclusion of uPA/PAI-1 for adjuvant treatment decision-making in ER+/Her2- pN0 early breast cancers.
Viala M; Alexandre M; Thezenas S; Lamy PJ; Maran-Gonzalez A; Gutowski M; Colombo PE; Romieu G; Jacot W; Guiu S
Breast Cancer Res Treat; 2017 Oct; 165(3):611-621. PubMed ID: 28685212
[TBL] [Abstract] [Full Text] [Related]
7. Incidence and Characteristics of Unsuspected Neoplasia Discovered in High-Risk Women Undergoing Risk Reductive Bilateral Salpingooophorectomy.
Poon C; Hyde S; Grant P; Newman M; Ireland Jenkin K
Int J Gynecol Cancer; 2016 Oct; 26(8):1415-20. PubMed ID: 27488216
[TBL] [Abstract] [Full Text] [Related]
8. clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): A comprehensive review.
Patrono MG; Iniesta MD; Malpica A; Lu KH; Fernandez RO; Salvo G; Ramirez PT
Gynecol Oncol; 2015 Dec; 139(3):568-72. PubMed ID: 26407480
[TBL] [Abstract] [Full Text] [Related]
9. Impact of breast cancer subtypes and patterns of metastasis on outcome.
Kast K; Link T; Friedrich K; Petzold A; Niedostatek A; Schoffer O; Werner C; Klug SJ; Werner A; Gatzweiler A; Richter B; Baretton G; Wimberger P
Breast Cancer Res Treat; 2015 Apr; 150(3):621-9. PubMed ID: 25783184
[TBL] [Abstract] [Full Text] [Related]
10. Side population cell level in human breast cancer and factors related to disease-free survival.
Jin C; Zou T; Li J; Chen X; Liu X; Wang Y; Wang X; Che Y; Wang X; Sriplung H
Asian Pac J Cancer Prev; 2015; 16(3):991-6. PubMed ID: 25735394
[TBL] [Abstract] [Full Text] [Related]
11. The potential role of estrogen receptor β2 in breast cancer.
Baek JM; Chae BJ; Song BJ; Jung SS
Int J Surg; 2015 Feb; 14():17-22. PubMed ID: 25450264
[TBL] [Abstract] [Full Text] [Related]
12. Retrospective analysis of clinicopathological factors and outcome in breast cancer in young women in a tertiary care hospital in India.
Deshmukh SP; Mane AD; Zade BP; Sane SP
Indian J Cancer; 2014; 51(4):594-8. PubMed ID: 26842207
[TBL] [Abstract] [Full Text] [Related]
13. The outcome of a quality-controlled mammography screening program: experience from a population-based study in Taiwan.
Pan HB; Wong KF; Yang TL; Hsu GC; Chou CP; Huang JS; Lee SK; Chou YH; Chiang CL; Liang HL
J Chin Med Assoc; 2014 Oct; 77(10):531-4. PubMed ID: 25103986
[TBL] [Abstract] [Full Text] [Related]
14. Metalloproteinase-dependent and -independent processes contribute to inhibition of breast cancer cell migration, angiogenesis and liver metastasis by a disintegrin and metalloproteinase with thrombospondin motifs-15.
Kelwick R; Wagstaff L; Decock J; Roghi C; Cooley LS; Robinson SD; Arnold H; Gavrilović J; Jaworski DM; Yamamoto K; Nagase H; Seubert B; Krüger A; Edwards DR
Int J Cancer; 2015 Feb; 136(4):E14-26. PubMed ID: 25099234
[TBL] [Abstract] [Full Text] [Related]
15. A dynamic clinical pathway for the treatment of patients with early breast cancer is a tool for better cancer care: implementation and prospective analysis between 2002-2010.
van Dam PA; Verheyden G; Sugihara A; Trinh XB; Van Der Mussele H; Wuyts H; Verkinderen L; Hauspy J; Vermeulen P; Dirix L
World J Surg Oncol; 2013 Mar; 11():70. PubMed ID: 23497270
[TBL] [Abstract] [Full Text] [Related]
16. Sequential docetaxel as adjuvant chemotherapy for node-positive or/and T3 or T4 breast cancer: clinical outcome (Mansoura University).
Sakr H; Hamed RH; Anter AH; Yossef T
Med Oncol; 2013 Mar; 30(1):457. PubMed ID: 23322524
[TBL] [Abstract] [Full Text] [Related]
17. Glutathione S-transferase Pi expression in invasive breast cancer and its relation with the clinical outcome.
Franco RL; Schenka NG; Schenka AA; Rezende LF; Gurgel MS
J BUON; 2012; 17(2):259-64. PubMed ID: 22740203
[TBL] [Abstract] [Full Text] [Related]
18. HER-3 status by immunohistochemistry in HER-2-positive metastatic breast cancer patients treated with trastuzumab: correlation with clinical outcome.
Gori S; Foglietta J; Mameli MG; Stocchi L; Fenocchio D; Anastasi P; Iacono D; Del Sordo R; Basurto C; De Angelis V; Sidoni A
Tumori; 2012; 98(1):39-44. PubMed ID: 22495700
[TBL] [Abstract] [Full Text] [Related]
19. Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases.
Nogami T; Shien T; Tanaka T; Nishiyama K; Mizoo T; Iwamto T; Ikeda H; Taira N; Doihara H; Miyoshi S
Breast Cancer; 2014 Jan; 21(1):58-65. PubMed ID: 22407396
[TBL] [Abstract] [Full Text] [Related]
20. Micrometastases or isolated tumor cells and the outcome of breast cancer.
de Boer M; van Deurzen CH; van Dijck JA; Borm GF; van Diest PJ; Adang EM; Nortier JW; Rutgers EJ; Seynaeve C; Menke-Pluymers MB; Bult P; Tjan-Heijnen VC
N Engl J Med; 2009 Aug; 361(7):653-63. PubMed ID: 19675329
[TBL] [Abstract] [Full Text] [Related]
[Next]
